期刊文献+

反相高效液相色谱法测定雷洛昔芬自微乳中的药物含量 被引量:2

RP-HPLC determination of raloxifene in raloxifene self-microemulsion
下载PDF
导出
摘要 目的建立雷洛昔芬自微乳中雷洛昔芬的含量测定方法。方法采用反相高效液相色谱法,以乙腈-0.01 mol·L^-1十二烷基硫酸钠溶液(体积比55:45)为流动相,紫外检测波长289 nm,流速1.0 m L·min^-1。结果雷洛昔芬在1.0-40.0μg·m L^-1与峰面积线性关系良好,回归方程为A=6.922×104C+1.716×104,r=0.999 9,平均回收率为101.3%,RSD为0.83%。结论该法简便、快速、重复性好,可用于雷洛昔芬自微乳中雷洛昔芬的质量控制。 Objective To establish the determination method of raloxifene in raloxifene self-microemulsion. MethodsRP-HPLC was used with the mobile phase consisting of acetonitrile-0.01 mol·L^- 1 twelve sodium dodecyl sulfate solution(volume ratio 55 : 45). The UV detection wavelength was 289 nm. The flow rate was 1.0 m L·min^- 1. Results Raloxifene was linear at 1.0- 40.0 μg·m L^- 1, A = 6.922×104C + 1.716×104, r = 0.999 9, and the average recovery of raloxifen was 101.3%, with RSD of 0.83%. Conclusion The method is rapid, simple, and highly reproducible, which can be used for the quality control of raloxifene in raloxifene self-microemulsion.
出处 《中南药学》 CAS 2015年第2期177-179,共3页 Central South Pharmacy
基金 中山市医学科研基金项目(No.2013A020168) 广东省科技计划项目(粤科规划字[2013]137号)
关键词 雷洛昔芬自微乳 反相高效液相色谱法 雷洛昔芬 含量测定 raloxifene self-microemulsion RP-HPLC raloxifene content determination
  • 相关文献

参考文献16

二级参考文献55

  • 1杨秀丽,孙进,何仲贵.格列吡嗪油水分配系数和平衡溶解度的测定[J].中国药剂学杂志(网络版),2009(3):121-126. 被引量:30
  • 2矫杰,孟迅吾.雷诺昔芬的研究进展[J].国外医学(内分泌学分册),2004,24(4):244-247. 被引量:2
  • 3吴宜勇,惠英,邓文慧,周钱,李燕春.盐酸雷洛昔芬防治绝经后骨质疏松症随机双盲对照研究[J].中国新药杂志,2004,13(8):741-744. 被引量:2
  • 4王金科 郭翠玲 等.雷洛昔芬[J].中国新药杂志,2000,9(2):124-124.
  • 5中华人民共和国药典委员会编.中国药典M[M].北京:化学工业出版社,2000.附录32.
  • 6Morgante G, Farina M, Cianei A, et al. Veralipfide administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women. Gynecol Endocrino1,2004 ;18(4): 194 ~ 198.
  • 7Drorith HC. Pharmacokinetics of raloxifene and its clinical application. European Journal of Obstetrics & Gynecologyand Reproductive Biology, 1999 ; 85:23 ~ 29.
  • 8Jeong E J, Liu Y, Lin H, et al. Speeies and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10. Drug Metab Dispos,2005 ;33(6) : 785 -794.
  • 9Jeong EJ, Lin H, Hu M. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model. J Pharmacol Exp Ther,2004 ;310 (1): 376 ~ 385.
  • 10David C, Frieder K, Metre H, et al. Raloxifene pharmaeokineties in males with normal and impaired renal function. Br J Clin Pharmacol,2004 ;59 (4): 479 ~ 482.

共引文献42

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部